PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.68 - 0.75
0.33 - 0.86
13.79M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.54%
Revenue growth above 1.5x 0425.HK's 1.18%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-15.02%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-30.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-30.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
2.50%
Net income growth under 50% of 0425.HK's 16.20%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.99%
EPS growth under 50% of 0425.HK's 16.46%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
-4.19%
Negative diluted EPS growth while 0425.HK is at 16.46%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.44%
Slight or no buybacks while 0425.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
7.00%
Diluted share count expanding well above 0425.HK's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
39.94%
Positive OCF growth while 0425.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
37.76%
Positive FCF growth while 0425.HK is negative. John Neff would see a strong competitive edge in net cash generation.
247.66%
10Y revenue/share CAGR at 50-75% of 0425.HK's 483.89%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
19.94%
5Y revenue/share CAGR under 50% of 0425.HK's 129.48%. Michael Burry would suspect a significant competitive gap or product weakness.
-10.19%
Negative 3Y CAGR while 0425.HK stands at 60.43%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-6520.63%
Negative 10Y OCF/share CAGR while 0425.HK stands at 342.57%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-394.38%
Negative 5Y OCF/share CAGR while 0425.HK is at 138.50%. Joel Greenblatt would question the firm’s operational model or cost structure.
-261.16%
Negative 3Y OCF/share CAGR while 0425.HK stands at 77.06%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
17.38%
Below 50% of 0425.HK's 349.78%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
27.23%
Below 50% of 0425.HK's 121.73%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
59.09%
3Y net income/share CAGR 50-75% of 0425.HK's 79.84%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
97.28%
5Y equity/share CAGR 1.25-1.5x 0425.HK's 66.92%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
6.65%
Below 50% of 0425.HK's 39.74%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
578.71%
5Y dividend/share CAGR 1.25-1.5x 0425.HK's 435.95%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
120.50%
3Y dividend/share CAGR above 1.5x 0425.HK's 64.72%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
44.39%
AR growth well above 0425.HK's 1.73%. Michael Burry fears inflated revenue or higher default risk in the near future.
-44.69%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
14.57%
Asset growth above 1.5x 0425.HK's 8.47%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.88%
50-75% of 0425.HK's 5.34%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
206.46%
Debt growth far above 0425.HK's 73.70%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-36.19%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-4.02%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.